Avidity Biosciences Inc — Quarterly Financial Statistics (NASDAQ:RNA) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Cash from operating activities -65.61 M-99.87 M-124.83 M-199.67 M-156.17 M-169.77 M -650.44 M Cash from investing activities -482.41 M-64.17 M157.19 M185.49 M-587.93 M207.22 M -38.03 M Cash from financing activities 342.46 M13.72 M1.94 M3.77 M850.37 M-5.09 M 850.99 M Free cash flow -67.32 M-103.79 M-128.58 M-203.01 M-156.88 M-175.28 M -663.76 M

뉴스

Morning News Wrap-Up 2/27/26: Today’s Biggest Stock Market Stories! - TipRanks.com

어비디티 바이오사이언스 Q1 실적, 수익 에상치보다 저조

Avidity Bio earnings missed by $0.30, revenue fell short of estimates

Avidity, 주주총회 연기… 합병 일정 발표

Avidity postpones stockholder meeting, sets merger dates

BB Biotech 2025 회계연도: 660% 이익 급증, 2026년 전망은 신중

아비디티, 근긴장성 이영양증 치료제 임상시험서 유망한 결과 보여

Avidity’s myotonic dystrophy drug shows promising results in trial

F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine

Vaccine Makers Curtail Research and Cut Jobs

U.S. Health Officials Defend Rejection of Moderna’s Flu Vaccine

F.D.A. Refuses to Review Moderna Flu Vaccine